Philips Healthcare’s (NYSE:PHG) Respironics unit is in the FDA’s cross-hairs after regulators inspected a manufacturing facility responsible for infant sleep apnea monitors that were the subject of a recall.
Inspectors said that the Philips’ facility failed to properly inspect battery packs before shipping them out with the Smart Monitor 2 Apnea Monitors.
Help employers find you! Check out all the jobs and post your resume.
